Edition:
India

Evolus Inc (EOLS.OQ)

EOLS.OQ on NASDAQ Stock Exchange Global Market

17.17USD
17 Sep 2019
Change (% chg)

$0.16 (+0.94%)
Prev Close
$17.01
Open
$16.97
Day's High
$17.25
Day's Low
$16.97
Volume
7,494
Avg. Vol
173,347
52-wk High
$30.25
52-wk Low
$10.29

Latest Key Developments (Source: Significant Developments)

Evolus Says Gross Margins May Fluctuate In The Future Due To Various Marketing Programs
Monday, 12 Aug 2019 

Aug 12 (Reuters) - Evolus Inc ::EVOLUS INC - GENERATED $2.3 MILLION IN JEUVEAU NET REVENUE IN Q2 2019.EVOLUS INC - QTRLY LOSS PER SHARE $1.37.EVOLUS INC - QTRLY NON-GAAP LOSS FROM OPERATIONS WAS $31.3 MILLION VERSUS $5.3 MILLION.EVOLUS INC - TOTAL CASH, CASH EQUIVALENTS, SHORT-TERM INVESTMENTS WERE $99.9 MILLION AS OF JUNE 30.EVOLUS INC - GROSS MARGIN MAY FLUCTUATE IN THE FUTURE DUE TO VARIOUS MARKETING PROGRAMS.  Full Article

Evolus Q3 Loss Per Share $0.48
Tuesday, 6 Nov 2018 

Nov 5 (Reuters) - Evolus Inc ::EVOLUS REPORTS THIRD QUARTER 2018 FINANCIAL RESULTS.Q3 LOSS PER SHARE $0.48.Q3 EARNINGS PER SHARE VIEW $-0.39 -- THOMSON REUTERS I/B/E/S.GRANTED MARKETING APPROVAL FOR DWP-450 BY HEALTH CANADA.REMAIN ON TRACK FOR ANTICIPATED U.S. COMMERCIAL LAUNCH OF DWP-450 IN SPRING 2019.TOTAL CASH WAS $105.2 MILLION AS OF SEPTEMBER 30, 2018, AN INCREASE OF $61.6 MILLION COMPARED TO JUNE 30, 2018.  Full Article

Evolus Granted Approval Of DWP-450 By Health Canada
Friday, 17 Aug 2018 

Aug 17 (Reuters) - Evolus Inc ::EVOLUS GRANTED APPROVAL OF DWP-450 BY HEALTH CANADA.EVOLUS - EXPECTS TO LAUNCH DWP-450 IN U.S. IN SPRING 2019, EXPECTS OPINION FROM COMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE BY Q1 2019.EVOLUS INC - WILL MARKET DWP-450 IN CANADA THROUGH ITS PARTNER CLARION MEDICAL TECHNOLOGIES, INC.  Full Article

Evolus Prices Public Offering Of 4 Mln Common Shares At $20/Share
Thursday, 19 Jul 2018 

July 18 (Reuters) - Evolus Inc ::EVOLUS, INC. ANNOUNCES PRICING OF PUBLIC OFFERING OF COMMON STOCK.SAYS PUBLIC OFFERING OF 4.00 MILLION COMMON SHARES PRICED AT $20.00PER SHARE.  Full Article

Evolus Says Co Offering Five Million Common Shares
Tuesday, 17 Jul 2018 

July 16 (Reuters) - Evolus Inc ::EVOLUS, INC. ANNOUNCES PROPOSED PUBLIC OFFERING OF COMMON STOCK.SAYS OFFERING 5.00 MILLION COMMON SHARES.  Full Article

Evolus Reports Q4 Earnings Per Share $0.24
Thursday, 29 Mar 2018 

March 29 (Reuters) - Evolus Inc ::EVOLUS REPORTS FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS.Q4 EARNINGS PER SHARE $0.24.EVOLUS- QTRLY NET INCOME PRIMARILY ATTRIBUTABLE TO FAVORABLE RE-MEASUREMENT OF DEFERRED TAX LIABILITY FROM DECREASE IN TAX RATES UNDER U.S. TAX ACT.  Full Article

Evolus Inc Shares Debut 6.3 Pct below IPO Price
Thursday, 8 Feb 2018 

Feb 8 (Reuters) - :EVOLUS INC SHARES OPEN AT $11.25 IN DEBUT ON THE NASDAQ VERSUS IPO PRICE OF $12 PER SHARE.  Full Article

Evolus Announces Pricing Of Initial Public Offering Of Common Stock
Thursday, 8 Feb 2018 

Feb 7 (Reuters) - Evolus Inc ::EVOLUS, INC. ANNOUNCES PRICING OF INITIAL PUBLIC OFFERING OF COMMON STOCK.SAYS INITIAL PUBLIC OFFERING OF 5.00 MILLION COMMON SHARES PRICED AT $12.00PER SHARE.  Full Article

UPDATE 1-Evolus reports sales of its Botox rival ahead of expectations

Aug 12 Medical aesthetics company Evolus Inc on Monday beat Wall Street estimates for second-quarter revenue from its newly launched rival to Allergan Plc's Botox, which has dominated the medical aesthetics market for more than a decade.